Pharmaceutical R&D functions at its best in small, agile and innovative SMEs. Replacing state subsidies and grant funding for research with start-up and development capital, would bring productivity improvements, says Mark Bloomfield, CEO of French biotech Polyplus Transfection
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.